Abstract
Two established activities of the multifunctional human hepatitis B virus X-protein are its transactivating and pro-apoptotic potential. We analysed whether X-proteins from other orthohepadnaviruses and the newly discovered avihepadnaviral X-proteins have similar functions as HBx. Previously, we have shown that HBx suppresses oncogenic transformation of primary rat embryo fibroblasts (REF) by induction of apoptosis. Using this system, we found that the wildtype X-proteins of woodchuck, ground squirrel, arctic squirrel and woolly monkey hepatitis B virus exhibit similar levels of pro-apoptotic activity as HBx, whereas mutants with carboxyterminal deletions were severely impaired in this activity. A strong correlation between the pro-apoptotic and transactivating abilities of the mammalian X-proteins was found. The newly discovered avihepadnaviral X-like proteins showed similar and Raf-MAPK pathway-dependent transactivating abilities and induced apoptosis in the REF-assay. Our data indicate that the transactivating and pro-apoptotic activities reside in the carboxyterminal half of orthohepadnaviral X and are conserved in avihepadnaviral X-proteins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andrisani OM, Barnabas S . 1999 Int. J. Oncol. 15: 373–379
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K . (eds). 1998 Current Protocols in Molecular Biology New York: John Wiley & Sons, Inc. pp 974–976
Beasley RP, Hwang LY, Lin CC, Chien CS . 1981 Lancet 2: 1129–1133
Becker SA, Lee TH, Butel JS, Slagle BL . 1998 J. Virol. 72: 266–272
Bergametti F, Prigent S, Luber B, Benoit A, Tiollais P, Sarasin A, Transy C . 1999 Oncogene 18: 2860–2871
Bouchard MJ, Wang LH, Schneider RJ . 2001 Science 294: 2376–2378
Buendia MA, Paterlini P, Tiollais P, Bréchot C . 1998 Viral hepatitis. 2nd. edn. Vol.?: Zuckerman AJ and Thomas CT (eds) London: Churchill Livingstone pp. 179–200
Chang SF, Netter HJ, Bruns M, Schneider R, Frölich K, Will H . 1999 Virology 262: 39–54
Chang SF, Netter HJ, Hildt E, Schuster R, Schaefer S, Hsu YC, Rang A, Will H . 2001 J. Virol. 75: 161–170
Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH . 1993 J. Virol. 67: 1218–1226
Chirillo P, Pagano S, Natoli G, Puri PL, Burgio VL, Balsano C, Levrero M . 1997 Proc. Natl. Acad. Sci. USA 94: 8162–8167
Colgrove R, Simon G, Ganem D . 1989 J. Virol. 63: 4019–4026
Cuende E, Ales-Martinez JE, Liyun D, Gonzalez-Garcia M, Martinez-A C, Nunez G . 1993 EMBO J. 12: 1555–1560
Dane DS, Cameron CH, Briggs M . 1970 Lancet 1: 695–698
Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, Woodgett JR, Penninger J, Richardson CD . 2001 J. Biol. Chem. 276: 8328–8340
Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, Will H, Harris CC . 1997 Proc. Natl. Acad. Sci. USA 94: 14707–14712
Feitelson MA, Miller RH . 1988 Proc. Natl. Acad. Sci. USA 85: 6162–6166
Gottlob K, Fulco M, Levrero M, Graessmann A . 1998a J. Biol. Chem. 273: 33347–33353
Gottlob K, Pagano S, Levrero M, Graessmann A . 1998b Cancer Res. 58: 3566–3570
Grethe S, Heckel JO, Rietschel W, Hufert FT . 2000 J. Virol. 74: 5377–5381
Hu X, Margolis HS, Purcell RH, Ebert J, Robertson BH . 2000 Proc. Natl. Acad. Sci. USA 97: 1661–1664
Huo TI, Wang XW, Forgues M, Wu CG, Spillare EA, Giannini C, Brechot C, Harris CC . 2001 Oncogene 20: 3620–3628
Kim CM, Koike K, Saito I, Miyamura T, Jay G . 1991 Nature 351: 317–320
Kim H, Lee H, Yun Y . 1998 J. Biol. Chem. 273: 381–385
Kim YC, Song KS, Yoon G, Nam MJ, Ryu WS . 2001 Oncogene 20: 16–23
Land H . 1995 Meth. Enzym. 254: 37–41
Land H, Parada LF, Weinberg RA . 1983 Nature 304: 596–602
Lanford RE, Chavez D, Brasky KM, Burns III RB, Rico Hesse R . 1998 Proc. Natl. Acad. Sci. USA 95: 5757–5761
Lanford RE, Chavez D, Rico-Hesse R, Mootnick A . 2000 J. Virol. 74: 2955–2959
Lee TH, Elledge SJ, Butel JS . 1995 J. Virol. 69: 1107–1114
Lin B, Anderson DA . 2000 Intervirology 43: 185–190
MacDonald DM, Holmes EC, Lewis JC, Simmonds P . 2000 J. Virol. 74: 4253–4257
Marion PL, Knight SS, Ho BK, Guo YY, Robinson WS, Popper H . 1984 Proc. Natl. Acad. Sci. USA 81: 898–902
Marion PL, Oshiro LS, Regnery DC, Scullard GH, Robinson WS . 1980 Proc. Natl. Acad. Sci. USA 77: 2941–2945
Marion PL, Van Davelaar MJ, Knight SS, Salazar FH, Garcia G, Popper H, Robinson WS . 1986 Proc. Natl. Acad. Sci. USA 83: 4543–4546
Mason WS, Seal G, Summers J . 1980 J. Virol. 36: 829–836
Murakami S . 1999 Intervirology 42: 81–99
Netter HJ, Chassot S, Chang SF, Cova L, Will H . 1997 J. Gen. Virol. 78: 1707–1718
Norder H, Ebert JW, Fields HA, Mushahwar IK, Magnius LO . 1996 Virology 218: 214–223
Oguey D, Dumenco LL, Pierce RH, Fausto N . 1996 Hepatology 24: 1024–1033
Popper H, Roth L, Purcell RH, Tennant BC, Gerin JL . 1987 Proc. Natl. Acad. Sci. USA 84: 866–870
Poussin K, Dienes H, Sirma H, Urban S, Beaugrand M, Franco D, Schirmacher P, Bréchot C, Paterlini Bréchot P . 1999 Int. J. Cancer 80: 497–505
Pult I, Netter HJ, Bruns M, Prassolov A, Sirma H, Hohenberg H, Chang SF, Frölich K, Krone O, Kaleta EF, Will H . 2001 Virology 289: 114–128
Runkel L, Fischer M, Schaller H . 1993 Virology 197: 529–536
Schuster R, Gerlich WH, Schaefer S . 2000 Oncogene 19: 1173–1180
Seeger C, Ganem D, Varmus HE . 1984 J. Virol. 51: 367–375
Seifer M, Höhne M, Schaefer S, Gerlich WH . 1991 Viral Hepatitis-1990. Hollinger F, Lemon S and Margolis H (eds) New York: Williams and Wilkins pp. 586–588
Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL . 2000 J. Biol. Chem. 275: 25858–25864
Shintani Y, Yotsuyanagi H, Moriya K, Fujie H, Tsutsumi T, Kanegae Y, Kimura S, Saito I, Koike K . 1999 J. Gen. Virol. 80: 3257–3265
Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, Kobayashi M, Koike K . 1989 Jpn. J. Cancer Res. 80: 617–621
Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Bréchot C . 1999 Oncogene 18: 4848–4859
Sitterlin D, Bergametti F, Tiollais P, Tennant BC, Transy C . 2000a Oncogene 19: 4427–4431
Sitterlin D, Bergametti F, Transy C . 2000b Oncogene 19: 4417–4426
Sitterlin D, Lee TH, Prigent S, Tiollais P, Butel JS, Transy C . 1997 J. Virol. 71: 6194–6199
Slagle BL, Lee TH, Medina D, Finegold MJ, Butel JS . 1996 Mol. Carcinog 15: 261–269
Sprengel R, Kaleta EF, Will H . 1988 J. Virol. 62: 3832–3839
Su F, Schneider RJ . 1997 Proc. Natl. Acad. Sci. USA. 94: 8744–8749
Summers J, Smolec JM, Snyder R . 1978 Proc. Natl. Acad. Sci. USA. 75: 4533–4537
Takada S, Shirakata Y, Kaneniwa N, Koike K . 1999 Oncogene 18: 6965–6973
Takahashi K, Brotman B, Usuda S, Mishiro S, Prince AM . 2000 Virology 267: 58–64
Terradillos O, Billet O . 1997 Oncogene 14: 395–404
Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P, Buendia MA . 1998 Oncogene 17: 2115–2123
Testut P, Renard CA, Terradillos O, Vitvitski Trepo L, Tekaia F, Degott C, Blake J, Boyer B, Buendia MA . 1996 J. Virol. 70: 4210–4219
Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Brechot P, Brechot C, Kremsdorf D . 2001 Cancer Res. 61: 7803–7810
Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Stürzbecher HW, Hoeijmakers JH, Harris CC . 1995 Cancer Res. 55: 6012–6016
Warren KS, Heeney JL, Swan RA, Heriyanto, Verschoor EJ . 1999 J. Virol. 73: 7860–7865
White E, Cipriani R, Sabbatini P, Denton A . 1991 J. Virol. 65: 2968–2978
Yu DY, Moon HB, Son JK, Jeong S, Yu SL, Yoon H, Han YM, Lee CS, Park JS, Lee CH, Hyun BH, Murakami S, Lee KK . 1999 J. Hepatol 31: 123–132
Zoulim F, Saputelli J, Seeger C . 1994 J. Virol. 68: 2026–2030
Acknowledgements
We thank B Luber (c-Ha-ras and c-myc), CW Distelhorst (Bcl-2) and E White (E1B) for providing the indicated constructs.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schuster, R., Hildt, E., Chang, SF. et al. Conserved transactivating and pro-apoptotic functions of hepadnaviral X protein in ortho- and avihepadnaviruses. Oncogene 21, 6606–6613 (2002). https://doi.org/10.1038/sj.onc.1205916
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205916